3 Stocks That Are Absurdly Cheap Right Now
To paraphrase an old saying, value is in the eye of the beholder. That said, with the stock market still near all-time highs, it's hard to find anything resembling a cheap stock. But it isn't impossible. Here's the proof.
Biotech Clovis Oncology (NASDAQ: CLVS) has been killed in the market, but there's a huge opportunity for one of its key drugs. Axon Enterprise (NASDAQ: AAXN) is shifting into a new business and using a software-as-a-service offering to keep customers in its ecosystem. And energy major ExxonMobil (NYSE: XOM) is showing signs that it's starting to turn its energy business around. Take a look and you'll probably find at least one of these stock has a place in your portfolio right now.
George Budwell (Clovis Oncology): Clovis Oncology, a biotech that has lost a staggering two-thirds of its value over the preceding 12 months, could turn out to be absurdly undervalued at current levels. This beaten-down biotech, after all, is trading at a ridiculous 0.66 times its projected 2025 revenue haul.
Quelle Fool.com
